Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)—-Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism…
The study was presented at ENDO 2019, Endocrine Society’s annual meeting DUARTE, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CityofHope?src=hash” target=”_blank”gt;#CityofHopelt;/agt;–The hemoglobin A1c blood test…
SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq:GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of EXJADE®1 (deferasirox)…
DUBLIN–(BUSINESS WIRE)–The “Alcohol Addiction – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau’s…
DUBLIN–(BUSINESS WIRE)–The “Diabetes Therapies Global Market Opportunities And Strategies To 2023” report has been added to ResearchAndMarkets.com’s offering. This report…
INNOVATE-3 will test the efficacy of Tumor Treating Fields combined with paclitaxel in patients with recurrent, platinum-resistant ovarian cancer ST.…
Application supported by the Phase 3 MAIA study for daratumumab in combination with lenalidomide and dexamethasone for the treatment of…
ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc. (“AgeX”, NYSE American: AGE), a biotechnology company focused on innovative therapeutics for human aging, announced…